Tag Archives: new drug development

ICYMI: Potential New Drug for Alzheimer’s Shows Promise in Early Trial

health care, medicine

Last week, the Washington Post published an article titled Alzheimer’s Drug Trial Sparks Optimism which highlighted new findings from a paper published in Nature. They shared exciting news of positive early trial results for a potential new Alzheimer’s treatment. “Overall this is the best news that we’ve had in my 25 years doing Alzheimer’s clinical research and it brings new hope for patients and families most affected by the disease,” said one of the study’s Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

8 Reasons New Medicines are Needed for Alzheimer’s

synthetic biology

Last week, the Alzheimer’s Association released an infographic with eight mythbusting facts to help dispel common misconceptions about the disease when it comes to prevention, financial impact, symptoms, and other areas. As the infographic confirms, there is no cure for this irreversible neurological disease, and only half of people living with Alzheimer’s (the 6th leading cause of death in the US) have actually been diagnosed. PhRMA’s report on Medicines in Development for Alzheimer’s Disease notes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

New Report Emphasizes the Role of Patent Protection in the Global Diffusion of New Drugs


A new report from the National Bureau of Economic Research (NBER) has determined that strong patent protection accelerates the speed at which new drugs are launched in different countries. Providing affordable access is often challenged by the need to provide adequate incentives for developing new drugs, and ensuring affordable prices once they develop. Often neglected in the larger debate is that the speed at which drugs are launched and adopted in new countries is one Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

A Bright Future for Orphan Disease Indications


In celebration of National Rare Disease Day BIO’s Industry Analysis team took a look at recently-approved drugs in the BioMedTracker database with an orphan indication designation. Our research found that 2012 saw the greatest number of approvals of therapies for orphan indications going back all the way to 2000 (This count includes previously approved drugs with new, orphan indication approvals).   Overall, 24 therapies were approved in orphan indications last year, including drugs for Anthrax, Gaucher’s Read More >

Inside BIO Industry Analysis  |  2 Comments  |  Email This Post
Tags: , , , , , , , , ,

Sequestration Will Be Devastating to the Cure Enterprise

Margaret Anderson

For months, the defense industry has taken the Hill and media outlets by storm detailing the potentially catastrophic impact “sequestration” will have on national security, defense jobs, and our economy. The “S” word stands for automatic spending cuts that will take into effect if Congress does not reach a budget agreement to reduce the deficit by the end of the year. Members of Congress have expressed concern over the potential cuts to defense programs, and even Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,